CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹3,481 Cr | ₹3,134 Cr | ₹2,563 Cr | ₹1,507 Cr | ₹1,031 Cr |
What is the latest Short Term Loans and Advances ratio of CIPLA ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2025 | ₹3,481 Cr |
| Mar2024 | ₹3,134 Cr |
| Mar2023 | ₹2,563 Cr |
| Mar2022 | ₹1,507 Cr |
| Mar2021 | ₹1,031 Cr |
How is Short Term Loans and Advances of CIPLA Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,481 Cr | 11.08 | |
| Mar2024 | ₹3,134 Cr | 22.28 | |
| Mar2023 | ₹2,563 Cr | 70.07 | |
| Mar2022 | ₹1,507 Cr | 46.18 | |
| Mar2021 | ₹1,031 Cr | - | |
Compare Short Term Loans and Advances of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹112,352.9 Cr | -1.6% | 5.6% | -5.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,909.0 Cr | -2.5% | 1% | 7.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,930.0 Cr | -3.1% | 0.3% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,181.0 Cr | -4.9% | 2.8% | 37.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,608.0 Cr | -3.2% | -3.1% | 4.8% | Stock Analytics | |
| MANKIND PHARMA | ₹95,809.4 Cr | -5.6% | 2.9% | -2.2% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -1.6% |
5.6% |
-5.7% |
| SENSEX | -1.5% |
-3.4% |
-9.1% |
You may also like the below Video Courses